{"name":"Crescendo Biologics Ltd.","slug":"crescendo-biologics-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi8wFBVV95cUxPMzZwaU5tZ0ZKdno5ODhvYkJ2Z3hsVlEzQkI2cWhENTNwMkQ5Z05mdzZpdmE2SmFqZnplTENHYklzU1V2VnNiY3AxR0phR3hfaXFjM1BIWlFZSUhCMlFqb1NCT3oxdWhkNXBrUFBNSi1NRHU5XzU2OWN4V1gtUERFNzZqcHRUWnJUNGJmU25MVVFDRlpjRHhZNmx1Zl9pUi1tajFqZmdMdVdzQTZncVcyMmxoTjNjYTJNMWNjcmtQdEwzb2ZLOW1TWWxJRTA4dl9xT1dVU00ybDhrZkpOQlZHaTc5a0tCaWF3ZU9aTXhqRkxsYWM?oc=5","date":"2023-07-24","type":"trial","source":"businesswire.com","summary":"Crescendo Biologics secures $32M and announces expansion of CB307 Phase 1b trial in PSMA+ solid tumours - businesswire.com","headline":"Crescendo Biologics secures $32M and announces expansion of CB307 Phase 1b trial in PSMA+ solid tumours","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxPYWJyd2prc3Z1ZFV6OGZ6NGx5ZnM2SzBVOFZJaUJiZzFFTTNKVFh6MElrQW1yNlQ5aDBPelhuRWZfZnpHTWlqY2MtU3R2QlNhcEdhUk1NZDlqckxBU1poUGsySzQ4QjdSUEZZYTZDbHVJWGtpOTJuNmJUYjBYeVhSSlgycWVSOGVXZHpnaXREQ1Z6b1E2SUM3TlhuWmxnRVBERXlFMHRsSk5wakZyWi1kMG9qVDI?oc=5","date":"2021-09-16","type":"pipeline","source":"businesswire.com","summary":"Crescendo to Participate in Upcoming Investor Conferences - businesswire.com","headline":"Crescendo to Participate in Upcoming Investor Conferences","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwJBVV95cUxPXzc3WHpEYl9IcHBIRGtfbVR5ZzJqeFZfSF9uRUd0OVVKZDFoUGVsUGVsVGhta3BWX0hJd0FfWkFwTFRxVmtSUDk0M2ZoSzQ3Q0ZhYXNYai1uLUdzZV9lTHd3QTJucVllcWlWeFg4d2xCdGhtU3hSNXFRVXFWTGxmT0gzd3hfUWhoOHlCZlRSMFhFbU0tTzVBNV9yWmtkeUdwNlQ1ZVBEbjdWVGJ1a3lyeEs4bkZKZ0czZ01WVjY4NjFmT19OeTRCYUdRUUExbXJYSHQ0WkE3ZUU2OE83Vk5OYlVjT3ZHd3FGMUF3cTBVUWc3Vkt0alRXYXBGOWNjQVR2c2hkbjJMS1lpQU5kWVZrd2hfRmxNaUVPQUJiZi1mWQ?oc=5","date":"2020-05-05","type":"deal","source":"businesswire.com","summary":"Crescendo Biologics and Cancer Research UK sign Clinical Development Partnership to develop CB213, a novel bispecific Humabody® therapeutic - businesswire.com","headline":"Crescendo Biologics and Cancer Research UK sign Clinical Development Partnership to develop CB213, a novel bispecific Hu","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxQdXNCVDF1WjcyLU0xdldMRGNLRWNqcnJfb25LX2JQM3QyUzJxbnpZMXEtVkdFeTNWLThwdy12ZGwwOWZ2aThOVXVOeUxsWGxIazhYX2p2b2Y3WXlkSHRrTkpYSkZxY1ZsTVZtanBaclJzdzl3eFIzZHQtb0F0S0FIMjJUSVkyMVNoMUthbUFzS091dw?oc=5","date":"2020-02-05","type":"pipeline","source":"PMLiVE","summary":"New hires at Crescendo, Healx and Galecto - PMLiVE","headline":"New hires at Crescendo, Healx and Galecto","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxQUVd2am9uT20tQy1BQVhtZVdhVFZVS0wtSGtJbmloT1RQRThwa2xhbXhpc2lIRk1OX0tnV2Q4WDhtWG5ab1g4UmlSVU8xM2tyTHAya1JuTnBfREJTSG5KQzVfZjRxRWZQdkpsZEcwRk5HSVdkWTJFejFUNEFKZVhacmczYjFHalF5WVE?oc=5","date":"2017-01-10","type":"pipeline","source":"Asian Scientist Magazine","summary":"Takeda & PvP Biologics To Develop Drugs Against Celiac Disease - Asian Scientist Magazine","headline":"Takeda & PvP Biologics To Develop Drugs Against Celiac Disease","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxNTXRLZldrOE5BRmt2MDJ5LWowYkQydEd6TzBiSnRZY1RjOE9scy0tLWMxMVRpM2Y4YUQwVE5mNktlWUFfUEN6SlhmaV9UVlB5dk90MkdKOWYya1RDSkt5UTczSGlLenBXdk9IdGZnblQzcFBVRVF5d1B4d0lIcWo2RkZMYWE0YU0?oc=5","date":"2016-11-01","type":"pipeline","source":"PMLiVE","summary":"Crescendo Biologics appoints CFO - PMLiVE","headline":"Crescendo Biologics appoints CFO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7gFBVV95cUxPenVUQTlqMy1VcUlIOUNiQ2FvVHQ0OHh5cmVMaVBBNnZsRHB5UC1pWFN0RDUzYmNGN1Z3TDNTYWFja0s2ZjBYZFhFT19JczNjdHY1cV9UWFZaaWoyTTJ3LTd0azE1Z0swU0IxQjBNODJtUHcyQWYwZzh6ZHd2NXpqQWl2WG8tbjRreTJCQ3BMWDVsRTRiWUpHby0ydF9VdGVUVUp2czdfNGN3ZTZjc0tvOFlRX0F1NzgzSnkzUUszelY1Z01ubEZjamUxX0xWT0JFaXYwOVMyclhVcXl1dV9SQ2ZRY2FlVkp2RHBIbmNB?oc=5","date":"2015-12-11","type":"patent","source":"Asian Scientist Magazine","summary":"Teva & Takeda Enter Joint Venture For Generics In Japan - Asian Scientist Magazine","headline":"Teva & Takeda Enter Joint Venture For Generics In Japan","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxPMG13bE15TFNiOVU3SXg0TUJRZjd0YWZRbTJsOHBYNk1icld3OE5NRjBFY2JVM0JoaEk4TzR6VkVCMzVSd1JLTHd5eUJxRGppbDNDRGxHWFI1YXlhVzFOM1lBeU5CelUyRkFyRkpkcURZTEZfbFNyWlJrWjFmUTdQMjZydEFLZ3FrSTlIVl9SRm81UVhIdGFjclNB?oc=5","date":"2014-01-03","type":"pipeline","source":"Asian Scientist Magazine","summary":"Takeda Submits New Drug Application For Fomepizole - Asian Scientist Magazine","headline":"Takeda Submits New Drug Application For Fomepizole","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxPLXNBTXZjc1FKcm9mQTZTUTlnQmFxd3RQNVhobkxnc0pIOVNXT3B6aC1qaHZaeXpIcTcxSVpiN3k1WkJhOXR4WklWdkVOZGZyMmwwZWhfSjNUOHBfMzFCdWdXYVJhYWlXbDJDREthVGpJTmRPNlZROEpBaU55aGV4bVA4bmgxclQ4VFJkRGhXYjhYUHRxOHFlWFM1RHdhMy13YnF3SzR1VnJ0cXFyXzZv?oc=5","date":"2013-08-06","type":"pipeline","source":"Asian Scientist Magazine","summary":"Oral Rheumatoid Arthritis Treatment XELJANZ® Launched In Japan - Asian Scientist Magazine","headline":"Oral Rheumatoid Arthritis Treatment XELJANZ® Launched In Japan","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxPbXZiQWY4WFgtNVdIUE9Ndy1YOWVjYll0bzlJMF9vVm1jYURVbkxEcmRNejFvT1NkOV94bEhQQjdDNG5hbzBNaWdTZ2p4ZVliV2JoOXllbEo3a0JrVW5kQ3pxbWV6YkpxU01Uc0FXNXNEb2Jud2U0N2VKM3FQckFraHd1MHBFOU5QRFE?oc=5","date":"2012-05-28","type":"deal","source":"Asian Scientist Magazine","summary":"Takeda To Acquire Brazil’s Multilab For US$250 Million - Asian Scientist Magazine","headline":"Takeda To Acquire Brazil’s Multilab For US$250 Million","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}